TheEdgeResearch
Home / Stocks / LMRI

Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

NASDAQ Healthcare Medical - Devices
$11.79 ▲ +1.07%
Market Cap
$1.13B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.99
52-Wk Range
6.45-19.45
CEO
Caitlin Zulla
Country
US
Currency
USD

Lumexa Imaging Holdings, Inc. Common Stock operates in the Medical - Devices industry of the Healthcare sector, headquartered in Raleigh, NC, US. The stock last traded at $11.79, up 1.07% on the session, giving a market capitalisation of $1.13B. On trailing twelve-month figures it carries a trailing P/E of -32.55, a net margin of -5.2%. Its beta of 0.99 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-32.55
Price / Sales
2.18
Price / Book
1.89
EV / EBITDA
42.15
Gross margin
10.5%
Operating margin
-0.6%
Net margin
-5.2%
Return on equity
Debt / equity
1.61
Current ratio
1.40
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
4,200
IPO date
2025-12-11
Headquarters
Raleigh, NC, US
About Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.

Comparable companies

Lumexa Imaging Holdings, Inc. Common Stock is most often compared with the following Healthcare names:

BSXBWAYCODXINSPIRTCPMIPOASPRCTSMLRXAIR
More research on LMRI
LMRI technical analysis LMRI TheEdge Score Compare against peers
Open full interactive analysis & DCF →